ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606499 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606499; 2) Community: the network communities that were significantly associated with the response to NSC 606499; 3) Molecule: the relationships between components within communities and NSC 606499; 4) MDR: the compounds that were significantly associated with the NSC 606499.

NSC Compound Enrichment Correlation
NSC 740618 (Z)-1-(2-chloro-5-(trifluoromethyl)phenyl)-4-(2-hydroxybenzylidene)-2-phenyl-1H-imidazol-5(4H)-one 0.00248668807445195 0.14628125
NSC 407809 Card-20(22)-enolide, 3-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.alpha.)- (9CI) 0.00304217761766482 0.45066703
NSC 11240 Aizen Victoria Blue BOH 0.00337662564965909 -0.21292413
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.00337662564965909 0.028948125
NSC 645931 Null 0.00337662564965909 -0.22783599
NSC 699934 Null 0.00337662564965909 0.02014167
NSC 609699 Topotecan hydrochloride 0.00366577979610622 0.89898071
NSC 665524 Null 0.00366577979610622 0.28562461
NSC 670289 Null 0.00366577979610622 0.055711266
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.00366577979610622 -0.20497814
Total:44  Current:3    [First] [Prev] [Next] [Last]